Feline viral rhinotracheitis
|Felid alphaherpesvirus 1|
Felid alphaherpesvirus 1
Feline viral rhinotracheitis (FVR) is an upper respiratory or pulmonary infection of cats caused by Felid alphaherpesvirus 1 (FeHV-1), of the family Herpesviridae. It is also commonly referred to as feline influenza, feline coryza, and feline pneumonia but, as these terms describe other very distinct collections of respiratory symptoms, they are misnomers for the condition. Viral respiratory diseases in cats can be serious, especially in catteries and kennels. Causing one-half of the respiratory diseases in cats, FVR is the most important of these diseases and is found worldwide. The other important cause of feline respiratory disease is feline calicivirus.
FVR is very contagious and can cause severe disease, including death from pneumonia in young kittens. It can cause flat-chested kitten syndrome, but most evidence for this is anecdotal. All members of the family Felidae are susceptible to FVR; in fact, FHV-1 has caused a fatal encephalitis in lions in Germany.
FVR is transmitted through direct contact only. It replicates in the nasal and nasopharyngeal tissues and the tonsils. Viremia (the presence of the virus in the blood) is rare. The virus is shed in saliva and eye and nasal secretions, and can also be spread by fomites. FVR has a two- to five-day incubation period. The virus is shed for one to three weeks postinfection. Latently infected cats (carriers) will shed FHV-1 intermittently for life, with the virus persisting within the trigeminal ganglion. Stress and use of corticosteroids precipitate shedding. Most disinfectants, antiseptics and detergents are effective against the virus.
Initial signs of FVR include coughing, sneezing, nasal discharge, conjunctivitis, and sometimes fever (up to 106) and loss of appetite. These usually resolve within four to seven days, but secondary bacterial infections can cause the persistence of clinical signs for weeks. Frontal sinusitis and empyema can also result.
FHV-1 also has a predilection for corneal epithelium, resulting in corneal ulcers, often pinpoint or dendritic in shape. Other ocular signs of FHV-1 infection include conjunctivitis, keratitis, keratoconjunctivitis sicca (decreased tear production), and corneal sequestra. Infection of the nasolacrimal duct can result in chronic epiphora (excess tearing). Ulcerative skin disease can also result from FHV-1 infection. FHV-1 can also cause abortion in pregnant queens, usually at the sixth week of gestation, although this may be due to systemic effects of the infection rather than the virus directly.
In chronic nasal and sinus disease of cats, FHV-1 may play more of an initiating role than an ongoing cause. Infection at an early age may permanently damage nasal and sinus tissue, causing a disruption of ciliary clearance of mucus and bacteria, and predispose these cats to chronic bacterial infections.
Diagnosis of FVR is usually by clinical signs, especially corneal ulceration. Definitive diagnosis can be done by direct immunofluorescence or virus isolation. However, many healthy cats are subclinical carriers of feline herpes virus, so a positive test for FHV-1 does not necessarily indicate that signs of an upper respiratory tract infection are due to FVR. Early in the course of the disease, histological analysis of cells from the tonsils, nasal tissue, or nictitating membrane (third eyelid) may show inclusion bodies (a collection of viral particles) within the nucleus of infected cells.
Treatment and prevention
Polyprenyl Immunostimulant is the only currently-approved treatment in the US for feline rhinotracheitis caused by herpesvirus. Effectiveness was demonstrated in a clinical study with cats experimentally infected with feline herpesvirus: 20 cats were treated with Polyprenyl Immunostimulant and 20 received a placebo; the study established that the severity of the disease was lower in the group treated with Polyprenyl Immunostimulant. Safety was demonstrated in 390 personally-owned cats from 2 days to 16 years of age, residing in 10 states (ibid).
Antibiotics are commonly used to prevent secondary bacterial infection. There are no specific antiviral drugs in common use at this time for FVR, although one study has shown that ganciclovir, PMEDAP, and cidofovir hold promise for treatment. More recent research has indicated that systemic famciclovir is effective at treating this infection in cats without the side effects reported with other anti-viral agents. More severe cases may require supportive care such as intravenous fluid therapy, oxygen therapy, or even a feeding tube. Conjunctivitis and corneal ulcers are treated with topical antibiotics for secondary bacterial infection. Lysine is commonly used as a treatment, however in a 2015 systematic review, where the authors investigated all clinical trials with cats as well as in vitro studies, concluded that lysine supplementation is likely not effective for the treatment or prevention of feline herpesvirus 1 infection.
There is a vaccine for FHV-1 available (ATCvet code: QI06AA08 (WHO), plus various combination vaccines), but although it limits or weakens the severity of the disease and may reduce viral shedding, it does not prevent infection with FVR. Studies have shown a duration of immunity of this vaccine to be at least three years. The use of serology to demonstrate circulating antibodies to FHV-1 has been shown to have a positive predictive value for indicating protection from this disease.
Preventing spread of virus
- "ICTV Taxonomy history: Felid alphaherpesvirus 1". International Committee on Taxonomy of Viruses (ICTV). Retrieved 9 January 2019.
- "ICTV 9th Report (2011) Herpesviridae". International Committee on Taxonomy of Viruses (ICTV). Retrieved 9 January 2019.
Felid herpesvirus 1 Felid herpesvirus 1 [FJ478159=NC_013590] (FeHV-1) (Feline rhinotracheitis virus)
- Carter, G.R.; Flores, E.F.; Wise, D.J. (2006). "Herpesviridae". A Concise Review of Veterinary Virology. Retrieved 2006-06-08.
- Ettinger, Stephen J.; Feldman, Edward C. (1995). Textbook of Veterinary Internal Medicine (4th ed.). W.B. Saunders Company. ISBN 978-0-7216-6795-9.[page needed]
- Maeda, Ken; Horimoto, Taisuke; Mikami, Takeshi (1998). "Properties and Functions of Feline Herpesvirus Type 1 Glycoproteins". Journal of Veterinary Medical Science. 60 (8): 881–8. doi:10.1292/jvms.60.881. PMID 9764399.
- Thiry, Etienne; Addie, Diane; Belák, Sándor; Boucraut-Baralon, Corine; Egberink, Herman; Frymus, Tadeusz; Gruffydd-Jones, Tim; Hartmann, Katrin; et al. (2009). "Feline herpesvirus infection. ABCD guidelines on prevention and management". Journal of Feline Medicine & Surgery. 11 (7): 547–55. doi:10.1016/j.jfms.2009.05.003. PMC 7129359. PMID 19481034.
- Stiles, J (1995). "Treatment of cats with ocular disease attributable to herpesvirus infection: 17 cases (1983–1993)". Journal of the American Veterinary Medical Association. 207 (5): 599–603. PMID 7649774.
- Holland, Jessica L.; Outerbridge, Catherine A.; Affolter, Verena K.; Maggs, David J. (2006). "Detection of feline herpesvirus 1 DNA in skin biopsy specimens from cats with or without dermatitis". Journal of the American Veterinary Medical Association. 229 (9): 1442–6. doi:10.2460/javma.229.9.1442. PMID 17078806.
- Johnson, Lynelle R.; Foley, Janet E.; De Cock, Hilde E. V.; Clarke, Heather E.; Maggs, David J. (2005). "Assessment of infectious organisms associated with chronic rhinosinusitis in cats". Journal of the American Veterinary Medical Association. 227 (4): 579–85. doi:10.2460/javma.2005.227.579. PMID 16117066.
- "Feline Respiratory Disease Complex". The Merck Veterinary Manual. 2006. Retrieved 2007-04-01.
- Legendre, Al (2017). "Polyprenyl Immunostimulant in Feline Rhinotracheitis: Randomized Placebo-Controlled Experimental and Field Safety Studies". Front. Vet. Sci. 4: 24. doi:10.3389/fvets.2017.00024. PMC 5326765. PMID 28289684.
- Van Der Meulen, K; Garré, B; Croubels, S; Nauwynck, H (2006). "In vitro comparison of antiviral drugs against feline herpesvirus 1". BMC Veterinary Research. 2: 13. doi:10.1186/1746-6148-2-13. PMC 1475582. PMID 16640781.
- Malik, R.; Lessels, N. S.; Webb, S.; Meek, M.; Graham, P. G.; Vitale, C.; Norris, J. M.; Power, H. (2009). "Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs". Journal of Feline Medicine & Surgery. 11 (1): 40–48. doi:10.1016/j.jfms.2008.11.012. PMID 19154974. S2CID 24590918.
- Bol, Sebastiaan; Bunnik, Evelien M. (2015). "Lysine supplementation is not effective for the prevention or treatment of feline herpesvirus 1 infection in cats: a systematic review". BMC Veterinary Research. 11: 284. doi:10.1186/s12917-015-0594-3. PMC 4647294. PMID 26573523.
- Gaskell, Rosalind; Dawson, Susan; Radford, Alan; Thiry, Etienne (2007). "Feline herpesvirus" (PDF). Veterinary Research. 38 (2): 337–54. doi:10.1051/vetres:2006063. PMID 17296160.
- Gore, TC; Lakshmanan, N; Williams, JR; Jirjis, FF; Chester, ST; Duncan, KL; Coyne, MJ; Lum, MA; Sterner, FJ (2006). "Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus". Veterinary Therapeutics : Research in Applied Veterinary Medicine. 7 (3): 213–22. PMID 17039444.
- Lappin, Michael R. (2006). Use of serological tests to determine vaccine needs. Proceedings of the North American Veterinary Conference.
|Wikimedia Commons has media related to Feline viral rhinotracheitis.|